Sort
10,829 grants matching “car t”
Engineering detours around the biologic barriers to allogeneic, iPSC-derived CAR T immunotherapy
$43,796Sang Pil Yoo · University Of California Los Angeles · F30 · FY2024 · CA
Immunology & Immunotherapy of Cancer Research Program (Project-006)
$43,761Robert S Negrin · Stanford University · P30 · FY2019 · CA
Oncofetal TNC CAR T Cell Therapy for Pediatric Sarcoma
$43,694Elizabeth Wickman · St. Jude Children'S Research Hospital Graduate School Of Biomedical Sciences, Llc · F31 · FY2023 · CA
A Mechanistic Model of Chimeric Antigen Receptor (CAR) Signaling Predicts the Effects of Co-Stimulatory Signaling on T cell Activation
$43,576Jennifer Ann Rohrs · University Of Southern California · F31 · FY2016 · CA
The role of CAR-expressing Tregs on antigen-specific immune suppression
$43,576Brenal Singh · University Of Pennsylvania · F31 · FY2016 · HL
Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness
$43,567Colin A Depp · University Of California, San Diego · R01 · FY2015 · MH
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
$43,443Daniel Harris · University Of Illinois At Urbana-Champaign · F30 · FY2018 · CA
Sexting as a mechanism for the role of alcohol in sexual assault
$43,120Allyson Lindsae Dir · Indiana University Indianapolis · F31 · FY2015 · AA
Improved Light Delivery for Optogenetics via Digital TRUE
$43,120Joshua Brake · California Institute Of Technology · F31 · FY2015 · EB
A Mechanistic Model of Chimeric Antigen Receptor (CAR) Signaling Predicts the Effects of Co-Stimulatory Signaling on T cell Activation
$43,120Jennifer Ann Rohrs · University Of Southern California · F31 · FY2015 · CA
NSF/DHS Workshop: Policy for Autonomy
$43,107Ryan Calo · University Of Washington · · FY2016 · CSE
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
$43,052James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Ecological Momentary Assessment of Unhealthy Exercise and Affect in Eating Disorders
$42,999Danielle April Nicole Iverson-Chapa · University Of Kansas Lawrence · R36 · FY2020 · MH
Development of Glypican-2 redirected T cells for the Treatment of Neuroblastoma
$42,753Matthew Bell · St. Jude Children'S Research Hospital Graduate School Of Biomedical Sciences, Llc · F31 · FY2022 · CA
Oncofetal TNC CAR T Cell Therapy for Pediatric Sarcoma
$42,752Elizabeth Wickman · St. Jude Children'S Research Hospital Graduate School Of Biomedical Sciences, Llc · F31 · FY2022 · CA
Mobile Applications for Depression: Comparing Cognitive and Behavioral Approaches
$42,676Colleen Stiles-Shields · Northwestern University At Chicago · F31 · FY2014 · MH
Sexting as a mechanism for the role of alcohol in sexual assault
$42,676Allyson Lindsae Dir · Indiana University Indianapolis · F31 · FY2014 · AA
ROLE OF ADENOVIRAL RECEPTORS IN GENE THERAPY OF DIABETES
$42,628Ohio State University · F32 · FY2000 · DK
HIV Treatment Strategies for Female Sex Workers Living with HIV in South Africa: Engagement Trajectories and Implementation Determinants
$42,566Carly Comins · Johns Hopkins University · F31 · FY2024 · MH
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
$42,553Daniel Harris · University Of Illinois At Urbana-Champaign · F30 · FY2013 · CA
Structure-guided protein evolution to develop improved natural ligand-based chimeric antigen receptor T cell therapy against CD70 in acute myeloid leukemia
$42,521Amrik Singh Kang · University Of California, San Francisco · F30 · FY2025 · CA
Engineering detours around the biologic barriers to allogeneic, iPSC-derived CAR T immunotherapy
$42,516Sang Pil Yoo · University Of California Los Angeles · F30 · FY2023 · CA
Biologic and Functional Characterization of In Vivo CAR-T cells
$42,485Kylie A Burdsall · Stanford University · F30 · FY2025 · CA
Mechanisms of CD8+ T cell-induced Innate Immune Activation
$42,479Charles Vallez · Cincinnati Childrens Hosp Med Ctr · F30 · FY2025 · AI
Center for Research and Education on Aging and Technology Enhancement - CREATE IV
$42,375Sara J. Czaja · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · AG